{"id":"https://openalex.org/A5116832169","orcid":"https://orcid.org/0009-0001-3663-772X","observed_orcids":["https://orcid.org/0009-0001-3663-772X"],"display_name":"Bismark Amofah","raw_author_names":["Bismark Amofah"],"full_name":"Bismark Amofah","works_count":5,"cited_by_count":40,"summary_stats":{"2yr_mean_citedness":8.0,"h_index":3,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5116832169","orcid":"https://orcid.org/0009-0001-3663-772X","observed_orcids":["https://orcid.org/0009-0001-3663-772X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},"years":[2026,2025]},{"institution":{"id":"https://openalex.org/I4210150756","ror":"https://ror.org/043cec594","display_name":"AstraZeneca (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","count":2,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","value":2.26e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":1.45e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12254","display_name":"Machine Learning in Bioinformatics","value":1.37e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","value":1.26e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","value":1.03e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","score":0.698678731918335},{"id":"41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","score":0.6362000107765198},{"id":"147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","score":0.5454000234603882},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.40036511421203613},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.3986538052558899}],"counts_by_year":[{"year":2025,"works_count":3,"oa_works_count":3,"cited_by_count":8},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":32}],"display_name_alternatives":["Bismark Amofah"],"block_key":"b amofah","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116832169","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5116832169","updated_date":"2026-11-12T13:17:38","created_date":"2025-03-28T00:00:00"}